WHITEHOUSE STATION, N.J. & PRINCETON, N.J.--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and GE Healthcare today announced a clinical study collaboration, license and supply agreement for use of [18F]Flutemetamol, an investigational positron emission tomography (PET) imaging agent, to support Merck's development of MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).
business unit
tags
BETHESDA, Md.--()--GE Capital, Healthcare Finan
business unit
tags
BETHESDA, MD -- December 17, 2012 --- GE Capital, Healthcare Financial Services announced today that it is serving as administrative agent on a $65 million senior secured credit facility for National
business unit
tags
FAIRFIELD, Conn. -- December 14, 2012 -- The Board of Directors of General Electric Company (NYSE: GE) today raised the Company's quarterly dividend by 12%, or $0.02 per outstanding share of the Company's common stock, to $0.19 per outstanding share of the Company's common stock. The Board declared that the dividend is payable January 25, 2013 to shareowners of record at the close of business on December 24, 2012. The ex-dividend date is December 20, 2012.
business unit
tags